BNT162b2 COVID-19 vaccine safe and efficacious in young children
1. A three-dose series of BNT162b2 was efficacious in eliciting an immune response and protecting children between six months and ...
Tag: bnt162b2
BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
1. The omicron BA.1-adapted BNT162b2 vaccine candidates elicited significant neutralizing antibodies against the omicron strains as well as the ancestral ...
BNT162b2 vaccine reduces rates of COVID-19 omicron variant infection in children
1. This national cohort study from Singapore showed a significant reduction in SARS-CoV-2 omicron variant infections in children vaccinated with ...
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
Third dose of BNT162b2 COVID-19 vaccine effective at decreasing risk of hospitalization [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Nationwide vaccination campaign with BNT162b2 mRNA vaccine reports high immunogenicity across all age groups [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
BNT162b2 mRNA vaccine for COVID-19 prevention [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males
1. The highest incidence of myocarditis or pericarditis was seen after the second dose of Moderna (mRNA-1273) in young men ...
BNT162b2 safe and efficacious in children 5 to 11 years of age
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11 years of ...
BNT162b2 vaccination after SARS-CoV-2 infection decreases risk of recurrent infection
1. In a retrospective cohort study of individuals who recovered from SARS-CoV-2, BNT162b2 vaccination decreased the risk of recurrent infection. ...